TORONTO, Canada - Ubika Research has issued an update report on Medworxx Solutions Inc. (TSX VENTURE: MWX) in a report, "Third quarter results confirm positive momentum" (dated December 4, 2009). Medworxx Solutions through its patient flow, learning and compliance products helps to improve patient care efficiency and knowledge management within hospitals and other health care organizations.
Ubika Research believes that Medworxx Solutions could leverage its strong customer base of over 300 hospitals in both Canada & US as a spring board to achieve top line revenue growth and achieve margin expansion with its recurring revenue model. Medworxx Solutions is rated "Speculative Buy" by Ubika Research, with a 12-month target of C$ 0.30.
Download the free report at:
http://www.smallcappower.com/microsite/CompanyDetail.aspx?CompanyID=14
About Medworxx Solutions Inc.
Medworxx Solutions Inc. (MWX-TSX-V) provides software for patient flow, compliance and education in the healthcare market. Hospitals across North America use its solutions to communicate, aggregate, and analyze knowledge in order to support decision making and regulatory compliance, reduce costs and improve operational efficiency. Based in Toronto, Canada, its marketing footprint spans nine provinces in Canada and 17 states in the U.S.
About Ubika Research
Ubika offers research, analytics and communications solutions to various areas of the financial services industry. We offer solutions that enhance revenue generation capabilities and provide clear competitive advantages. For more information visit
www.ubikaresearch.com About Smallcappower.com
Smallcappower.comprovides a premier platform for small and micro-cap companies to showcase their investment potential and to reach to a wide audience of thousands of investors in a thoughtful, comprehensive and engaging manner.
Disclosure
Except for the historical information presented herein, matters discussed in this document contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements.
Ubika Research, a division of Ubika Corporation, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this report. For making specific investment decisions, readers should seek their own advice.
For full disclosure please visit: http://www.smallcappower.com/microsite/CompanyDetail.aspx?CompanyID=14
For additional information contact:
Vishy Karamadam,Managing Director
vishy@ubikacorp.com
